Significance of the Sulfonamide Component for the Clinical Efficacy of Trimethoprim-sulfonamide Combinations

References

• Stille W. The prognostic value of the antibiogram. Infection 1983; 11: 66–70, Suppl
   Web of Science ®Google Scholar
• Lacey R W. Disparities between activities of antibacterial agents in vitro and in vivo. The betalactam antibiotics: Penicillins and cephalosporins in perspective, S Selwyn. Hodder and Stoughton, London 1980; 245–254
   Google Scholar
• Wormser G P, Keusch G T, Heel R C. Co-trimoxazole (trimethoprim-sulfamethoxazole). An updated review of its antibacterial activity and clinical efficacy. Drugs 1982; 24: 459–518
   PubMed Web of Science ®Google Scholar
• Nordbring F. Swedish experience of intravenous trimethoprim-sulphamethoxazole treatment. Urinary tract infections. Current aspects of pathogenesis, prognosis and trimethoprim-sulphamethoxazole therapy, F Nordbring, L G Burman. Almqvist & Wiksell International, Stockholm 1981; 141–144
   Google Scholar
• Schmidt U, Sen P, Kapila R, Louria D B. Clinical evaluation of intravenous trimethoprim-sulfamethoxazole for serious infections. Rev Infect Dis 1982; 4: 332–337
   PubMedGoogle Scholar
• Salter A J. Trimethoprim-sulfamethoxazole in treatment of severe infections. Rev Infect Dis 1982; 4: 338–350
   PubMedGoogle Scholar
• Anderson J D, Lacey R W, Lewis E L, Sellin M A. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection. J Clin Pathol 1974; 27: 619–622
   PubMed Web of Science ®Google Scholar
• Grüneberg R N. The microbiological rationale for the combination of sulfonamides with trimethoprim. J Antimicrob Chemother 1979; 5: 27–36, Suppl B
   PubMed Web of Science ®Google Scholar
• Trimethoprim. Lancet 1980; 1: 519–520, Anonymous
   Web of Science ®Google Scholar
• Brumfitt W, Hamilton-Miller J MT. Co-trimoxazole or trimethoprim alone? A viewpoint on their relative place in therapy. Drugs 1982; 24: 453–458
   PubMed Web of Science ®Google Scholar
• Burman L G. Resistance to trimethoprim. Lancet 1980; 1: 1409
   PubMedGoogle Scholar
• Burman L G. The antimicrobial activities of trimethoprim and sulfonamides. Scand J Infect Dis 1986; 18: 3–13
   PubMed Web of Science ®Google Scholar
• Lewis E L, Anderson J D, Lacey R W. A reappraisal of the antibacterial action of cotrimoxazole in vitro. J Clin Pathol 1974; 27: 87–91
   PubMed Web of Science ®Google Scholar
• Stokes A, Lacey R W. Effect of thymidine on activity of trimethoprim and sulphamethoxazole. J Clin Pathol 1978; 31: 165–171
   PubMed Web of Science ®Google Scholar
• Lacey R W, Rogerson J G, Stokes A. Antimicrobial effects of trimethoprim and sulphadiazine in infected urine and blood. J Med Microbiol 1980; 13: 121–132
   PubMed Web of Science ®Google Scholar
• Japan cooperative bacteriological study group for co-trimoxazole. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan. J Infect Dis 1973; 128: 502–507, Suppl
   Web of Science ®Google Scholar
• Rawal B D, Cottis L. Evaluation of in vitro sensitivity testing methods for detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay. Arzneim Forsch/Drug Res 1980; 30: 1049–1051
   PubMed Web of Science ®Google Scholar
• Grunberg E. The effect of trimethoprim on the activity of sulfonamides and antibiotics in experimental infections. J Infect Dis 1973; 128: 478–485, Suppl
   Web of Science ®Google Scholar
• White G, Piercy W T, Gibbs H A. Use of a calf salmonellosis model to evaluate the therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo. Res Vet Sci 1981; 31: 27–31
   PubMed Web of Science ®Google Scholar
• Nottebrock H, Then R L. Thymidine concentrations in serum and urine of different animal species and man. Biochem Pharmacol 1977; 26: 2175–2179
   PubMed Web of Science ®Google Scholar
• Then R L. Role of thymidine for the activity of trimethoprim, sulfonamides and their combinations. Zentralbl Bakteriol Hyg [Orig A] 1980; 247: 483–494
   Google Scholar
• Wilkinson P J, Reeves D S. Tissue penetration of trimethoprim and sulphonamides. J Antimicrob Chemother 1979; 5: 159–168, Suppl B
   PubMed Web of Science ®Google Scholar
• Kamme C, Melander A, Nilsson N-I. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: Relation between saliva concentrations and in vivo activity against nasopharyngeal pathogens. Scand J Infect Dis 1983; 15: 107–113
   PubMed Web of Science ®Google Scholar
• Gossius G, Storvold G. Trimethoprim, med eller utan sulfonamid?. Tidsskr Nor Laegeforen 1983; 103: 1681–1683
   PubMedGoogle Scholar
• Watson I D, Cohen H N, McIntosh S J, Thomson J A, Shenkin A. Synergism between trimethoprim and sulfonamide in urine, does it exist?. Clin Therapeutics 1981; 4: 103–108
   PubMed Web of Science ®Google Scholar
• Svedhem Å, Iwarson S. Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment. J Antimicrob Chemother 1979; 5: 717–720
   PubMed Web of Science ®Google Scholar
• Fair W R, Crane D B, Schiller N, Heston W DW. A reappraisal of treatment in chronic bacterial prostatitis. J Urol 1979; 121: 437–441
   PubMed Web of Science ®Google Scholar
• Hofstetter V A, Friesen G, Bishop-Freudling G B, Vergin H. Co-trimoxazol-Konzentration in Prostatasekret von Patienten mit subakuter und chronischer Prostatitis. Fortschr Med 1984; 102: 244–246
   PubMedGoogle Scholar
• Burman L G, Östensson R. Plasmids and chromosomal resistance to co-trimoxazole of urinary pathogens and faecal bacteria in Sweden. Urinary tract infections, Current aspects of pathogenesis, prognosis and trimethoprim-sulphamethoxazole therapy, F Nordbring, L G Burman. Almqvist & Wiksell International, Stockholm 1981; 37–42
   Google Scholar
• Koch A E, Burchall J J. Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Appl Microbiol 1971; 22: 812–817
   PubMedGoogle Scholar
• Maskell R, Okubadejo O A, Payne R H, Pead L. Human infections with thymine-requiring bacteria. J Med Microbiol 1977; 11: 33–45
   Web of Science ®Google Scholar
• Platt D J, Guthrie A J, Langan C E. The isolation of thymidine-requiring Haemophilus influenzae from the sputum of chronic bronchitic patients receiving trimethoprim. J Antimicrob Chemother 1983; 11: 281–286
   PubMed Web of Science ®Google Scholar
• King C H, Shlaes D M, Dul M J. Infection caused by thymidine-requiring trimethoprim-resistant bacteria. J Clin Microbiol 1983; 18: 79–83
   PubMed Web of Science ®Google Scholar
• Amyes S GB, Smith J T. Thymineless mutants and their resistance to trimethoprim. J Antimicrob Chemother 1975; 1: 85–89
   PubMedGoogle Scholar
• Edmunds P N. Synergy between sulphonamide and trimethoprim in the presence of pus. J Clin Pathol 1978; 31: 162–164
   PubMedGoogle Scholar
• Spink W W. The nature of brucellosis. Minnesota University Press, Minneapolis 1956
   Google Scholar
• Daikos G K, Papapolyzos N, Marketos N, Mochlas S, Kasanakis S, Papasteriadis E. Trimethoprim-sulfamethoxazole in brucellosis. J Infect Dis 1973; 128: 731–733, Suppl
   Google Scholar
• Wright D MJ, Grimble A S. Sulphamethoxazole combined with 2, 4-diaminopyrimidines in the treatment of gonorrhoea. Br J Vener Dis 1970; 46: 34–36
   PubMedGoogle Scholar
• Csonka G W, Knight G J. Therapeutic trial of trimethoprim as potentiator of sulphonamides in gonorrhoea. Br J Vener Dis 1967; 43: 161–165
   PubMedGoogle Scholar
• Csango P A, Salveson A, Gundersen T, Garletta J, Bjerk O. Treatment of acute gonococcal urethritis in men with simultaneous infection with Chlamydia trachomatis. Br J Vener Dis 1984; 60: 95–98
   PubMedGoogle Scholar
• Stamm W E, Guinan M E, Johnson C, Starcher T, Holmes K K, McCormack W M. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984; 310: 545–549
   PubMed Web of Science ®Google Scholar
• Austin T W, Brooks G F, Bethel M, Roberts F L, Turck M, Holmes K K. Trimethoprim-sulfamethoxazole in the treatment of gonococcal urethritis: Clinical and laboratory correlates. J Infect Dis 1973; 128: 666–672, Suppl
   Google Scholar
• Lawrence A, Phillips I, Nicol C. Various regimens of trimethoprim-sulfamethoxazole used in the treatment of gonorrhea. J Infect Dis 1973; 128: 673–678, Suppl
   Google Scholar
• Wallace R J, Septimus E J, Jr., Williams T W, Jr., Conklin R H, Satterwhite T K, Bushby M B, Hollowell D C. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis 1982; 4: 315–325
   PubMedGoogle Scholar
• Johannisson G EB, Lycke B E. Chlamydia trachomatis infections and venereal disease. Acta Derm Venereol 1977; 57: 455–458
   PubMed Web of Science ®Google Scholar
• Johannisson G EB, Sernryd A, Lycke B E. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo. Sex Transm Dis 1979; 6: 50–57
   PubMed Web of Science ®Google Scholar
• Greenwood D, O'Grady F. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. J Clin Pathol 1976; 29: 162–166
   PubMed Web of Science ®Google Scholar
• Brumfitt W, Pursell R. Double blind trial to compare ampicillin, cephalexin, co-trimoxazole and trimethoprim in treatment of urinary infection. Br Med J 1972; 2: 673–676
   PubMed Web of Science ®Google Scholar
• Mabeck C E, Vejlsgaard R. Treatment of urinary tract infections in general practice with sulfamethizole, trimethoprim or co-trimazine (sulphadiazine-trimethoprim). J Antimicrob Chemother 1980; 6: 701–708
   PubMed Web of Science ®Google Scholar
• Kasanen A, Sundquist H, Elo J, Anttila M, Kangas L. Secondary prevention of urinary tract infections. The role of trimethoprim alone. Ann Clin Res 1983; 15, Suppl 36
   PubMedGoogle Scholar
• Gleckman R A. A cooperative controlled study of the use of trimethoprim-sulfamethoxazole in chronic urinary tract infections. J Infect Dis 1973; 128: 647–651, Suppl
   PubMedGoogle Scholar
• Sourander L, Saarimaa R, Arvilommi H. Treatment of sulfonamide-resistant urinary tract infections with a combination of sulfonamide and trimethoprim. Acta Med Scand 1972; 191: 1–3
   PubMed Web of Science ®Google Scholar
• Rundle J SM, Scott R. Co-trimoxazole and trimethoprim in complicated urinary tract infection. Urology 1983; 21: 645–647
   PubMed Web of Science ®Google Scholar
• Cox C E, Montgomery W G. Combined trimethoprim-sulfisoxazole therapy of urinary infections. Postgrad Med J 1969; 45, Suppl 65
   PubMedGoogle Scholar
• Lacey R W, Lord V L, Gunasekera H KW, Leiberman P J, Luxton D EA. Comparison of trimethoprim alone with trimethoprim-sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance. Lancet 1980; 1: 1270–1273
   PubMed Web of Science ®Google Scholar
• Ashford J J, Downey L J. A multi-centre study comparing trimethoprim and co-trimoxazole in the treatment of respiratory tract infection in general practice. Br J Clin Pract 1982; 36: 152–156
   PubMedGoogle Scholar
• Hughes D TD. Use of combinations of trimethoprim and sulphonamides in the treatment of chest infections. J Antimicrob Chemother 1983; 12: 423–434
   PubMed Web of Science ®Google Scholar
• Hughes D TD. Use of combinations of trimethoprim and sulfamethoxazole in the treatment of chest infections. J Infect Dis 1973; 128: 701–705, Suppl
   Web of Science ®Google Scholar
• Hughes D TD, Russel N J. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections. Rev Infect Dis 1982; 4: 528–532
   PubMedGoogle Scholar